Jim Golubieski, president of the Foundation for Health Advancement.

Founders and investors share their experience in startup success in a virtual panel discussion co-sponsored by the Foundation for Health Advancement (FHA) and Princeton Innovation Center BioLabs on Wednesday, December 2, at 2 p.m.

The program, titled “Navigating the Path to Startup Success,” is part of the ongoing Innovate and Impact series that seeks to provide education, share best practices and lessons learned, and offer networking opportunities for entrepreneurs, innovators, investors, researchers, students, and businesses. Registration is required for the free program via EventBrite. Visit www.princetonbiolabs.com for more information.

Panelists include:

Jim Golubieski is the president of the Foundation for Health Advancement and its affiliates, the New Jersey Health Foundation and Foundation Venture Capital Group.

The FHA is a Forrestal Village-based nonprofit organization whose programs grow new science-based businesses in collaboration with New Jersey-based research institutions and inspire students to pursue STEM majors and careers.

It supports researchers at the Kessler Foundation, NJIT, Princeton University, Rowan University, Rutgers University, and Stevens Institute of Technology. Visit www.foundationforhealthadvancement.org for more information.

Prior to assuming his role at FHA, Golubieski, a CPA, was the CFO of Array Medical, a medical device startup that developed a novel blood test for platelet function and was subsequently acquired.

John Frankel is the founder of New York City-based ff Venture Capital, which specializes in providing seed and early-stage funding to technology companies. He previously spent 21 years with Goldman Sachs.

Michael Johnson is the founder of Visikol, a bio-imaging company he founded as a PhD candidate in applied microbiology at Rutgers that has since been spun off from the university.

Brian Mulhall founded and led Whitehouse Analytical Laboratories, a facility that served the quality control testing needs of the pharmaceutical and biotechnology industries. He grew the company from three employees in a small space to a 48-employee firm in over 24,000 square feet that was ultimately acquired by the publicly traded company Albany Molecular Research.

Mulhall now acts as an equity investor in pharma-related startups, including Visikol, to which he is also a consultant.

Ari Rabban is the co-founder and CEO of Phone.com, a cloud communications service provider based in New Jersey. He previously served a senior executive at VocalTec Communications and helped found, manage, and sell three VoIP businesses. He is on the boards of USPharma Labs and the New Jersey Technology Council.

The panel will be moderated by Mike Wiley, the vice president of the New Jersey Health Foundation and Foundation Venture Capital Group.

He previously worked in business development, new venture financing, program/product development, commercial contracting, and intellectual property/technology licensing for organizations such as the New Jersey Economic Development Authority, Rutgers University’s Office of Corporate Liaison and Technology Transfer, and Lucent Technologies.

Princeton Innovation Center Biolabs, based on College Road East in Plainsboro, is a coworking space for New Jersey-based science startups.


Facebook Comments